Otsuka Holdings Co., Ltd. Otsuka Group News RSS http://otsuka.com Otsuka Holdings Co., Ltd. Otsuka Group News RSS Mon, 15 Jun 2026 09:00:00 +0900 Mon, 15 Jun 2026 09:00:00 +0900 60 Otsuka Pharmaceutical Completes Acquisition of Transcend Therapeutics https://www.otsuka.co.jp/en/company/newsreleases/2026/20260615_1.html Mon, 15 Jun 2026 09:00:00 +0900 1593 Otsuka Foods’ Biwako Research Institute Develops “Oishisa LENS,” an AI System That Predicts Flavor Profiles and Recipes to Secure Expertise Transfer and Enhance Product Design 58 Years After the Brand’s Launch, Preserving Bon Curry’s Signature Taste for the Next Generation https://www.otsukafoods.co.jp/en/news/20260611.html Thu, 11 Jun 2026 09:00:00 +0900 1592 Otsuka Establishes “Heatstroke Countermeasure Industry-Government-Academia Consortium” with the National Institute for Environmental Studies and Other Partners https://www.otsuka.co.jp/en/company/newsreleases/2026/20260605_1.html Fri, 05 Jun 2026 09:00:00 +0900 1590 Otsuka Presents Positive Interim Phase 3 VISIONARY eGFR Data Showing VOYXACT (sibeprenlimab-szsi) Preserved Kidney Function Over 12 Months in IgA Nephropathy (IgAN) https://www.otsuka.co.jp/en/company/newsreleases/2026/20260605_2.html Fri, 05 Jun 2026 09:00:00 +0900 1591 Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting https://www.otsuka.co.jp/en/company/newsreleases/2026/20260529_1.html Fri, 29 May 2026 09:00:00 +0900 1589 Otsuka Launches New Program FACEDUO “Heat Illness Prevention VR” Enabling Early Awareness and Action Through Simulated Experiences to Help Prevent the Onset and Severity of Heat Illness in Older Adults https://www.otsuka.co.jp/en/company/newsreleases/2026/20260518_1.html Mon, 18 May 2026 09:00:00 +0900 1588 U.S. FDA Approves INQOVI® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy https://www.taiho.co.jp/en/release/2026/20260514.html Thu, 14 May 2026 09:00:00 +0900 1587 Otsuka Launches “Educational Materials and Resources by Otsuka” for Educators to Support Health Education in Schools Providing Free Digital Health Education Materials on Heat Illness Prevention and Nutrition Education https://www.otsuka.co.jp/en/company/newsreleases/2026/20260430_1.html Thu, 30 Apr 2026 09:00:00 +0900 1585 U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations https://www.taiho.co.jp/en/release/2026/20260428_1.html Tue, 28 Apr 2026 09:00:00 +0900 1586 Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development https://www.taiho.co.jp/en/release/2026/20260428.html Tue, 28 Apr 2026 09:00:00 +0900 1584